Objectives

After participating in this educational activity, attendees should be able to:

  1. Describe mechanism of action of methotrexate.
  2. Identify 3 potential toxicities of methotrexate.
  3. Discuss management of methotrexate neurotoxicity.
  4. Recognize signs and symptoms of transient myeloproliferative disorder.
  5. Explain the relationship between TMD and trisomy 21.
     

Faculty

Matthew Richardson, MD
Assistant Professor of Pediatrics
University of Massachusetts Medical School-Baystate

Joanna Luty, MD
Assistant Professor of Pediatrics
University of Massachusetts Medical School-Baystate

Commercial Relationships: None

Session date: 
Tuesday, September 4, 2018 - 8:00am to 9:00am
Location: 
Baystate Medical Center
759 Chestnut Street
Chestnut 1 A & B
Springfield, MA 01199
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 BCIPE Instructional Hours

Please login or register to take this course.